Microbix Biosystems (TSX:MBX) Change In Payables And Accrued Expense : C$0.30 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Change In Payables And Accrued Expense?

Microbix Biosystems's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was C$0.07 Mil. It means Microbix Biosystems's Accounts Payable & Accrued Expense increased by C$0.07 Mil from Dec. 2023 to Mar. 2024 .

Microbix Biosystems's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2023 was C$0.25 Mil. It means Microbix Biosystems's Accounts Payable & Accrued Expense increased by C$0.25 Mil from Sep. 2022 to Sep. 2023 .

Microbix Biosystems Change In Payables And Accrued Expense Historical Data

The historical data trend for Microbix Biosystems's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Change In Payables And Accrued Expense Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.30

0.02

0.18

-0.22

0.25

Microbix Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.18	0.76	-0.22	-0.32	0.07

Microbix Biosystems Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.30 Mil.

Microbix Biosystems Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems (TSX:MBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

James Stuart Currie

Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines